The utility of magnetic resonance imaging in prostate cancer diagnosis in the Australian setting.

Jia Ying Isaac Tay,Ken Chow,Dominic J Gavin,Evie Mertens,Nicholas Howard,Benjamin Thomas,Philip Dundee,Justin Peters,Paul Simkin, Sevastjan Kranz,Moira Finlay,Stefan Heinze,Brian Kelly,Anthony Costello,Niall Corcoran

BJUI compass（2021）

引用 3|浏览5

暂无评分

摘要

MRI has good sensitivity and negative predictive value for clinically significant prostate cancers. It is useful as a pre-biopsy tool and can be used to significantly reduce the number of unnecessary prostate biopsies. However, MRI does not significantly improve risk predictions for clinically significant cancers when incorporated into the ERSPC risk calculator.

查看译文

关键词

ERSPC risk calculator,active surveillance,biopsy,multiparametric magenetic resonance imaging,prostate Cancer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要